Elacridar CAS 143664-11-3: Potent P-gp and BCRP Inhibitor for Enhanced Drug Efficacy
Discover the power of Elacridar (CAS 143664-11-3), a leading P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP) inhibitor. As a premier manufacturer and supplier in China, we provide high-purity Elacridar to empower your research in overcoming multidrug resistance and optimizing drug delivery.
Get a Quote & SampleUnlock New Therapeutic Potentials with Elacridar
Elacridar (CAS 143664-11-3)
Elacridar is a highly effective pharmaceutical intermediate and research chemical that acts as a potent inhibitor of key efflux transporters, P-glycoprotein (P-gp/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2). By blocking these transporters, Elacridar helps researchers buy time for therapeutic agents to remain within cells, thereby increasing their efficacy and overcoming multidrug resistance. We are a trusted supplier offering competitive pricing for Elacridar in China, ensuring reliable sourcing for your pharmaceutical development needs.
- High Purity Elacridar for Reliable Research: Ensure accurate results with our ≥98% purity Elacridar, a critical factor for demanding pharmaceutical research and drug development.
- Overcome Multidrug Resistance (MDR): Utilize Elacridar as a key component in strategies to combat MDR, a significant challenge in cancer therapy and other disease treatments.
- Enhance Drug Bioavailability and Brain Penetration: Our Elacridar supplier services facilitate improved drug delivery, including enhanced brain penetration of P-gp substrates, vital for CNS-targeted therapies.
- Trusted Manufacturer & Supplier in China: Secure your supply chain with a reputable manufacturer offering competitive Elacridar prices and prompt delivery for your purchase requirements.
Key Advantages of Our Elacridar Offering
Potent Inhibition of ABC Transporters
Elacridar exhibits potent inhibitory activity against both P-gp and BCRP, making it an invaluable tool for research into drug transport mechanisms and strategies to overcome resistance. Explore how buying Elacridar can benefit your drug discovery programs.
Enhance Therapeutic Agent Efficacy
By preventing the efflux of drugs from cells, Elacridar significantly boosts the intracellular concentration and therapeutic effect of co-administered agents. Purchase Elacridar to improve outcomes in cancer research and beyond.
Supports CNS Drug Delivery Research
Elacridar's ability to enhance brain penetration of P-gp substrates makes it crucial for developing therapies targeting central nervous system disorders. Contact us to buy Elacridar for your neuroscience research needs.
Diverse Applications in Biomedical Research
Cancer Therapy Research
Elacridar is widely employed in studies aimed at reversing multidrug resistance in various cancer cell lines and models. We are a leading supplier for researchers looking to purchase Elacridar for oncology applications.
Drug Discovery and Development
As a critical pharmaceutical intermediate, Elacridar aids in understanding drug pharmacokinetics and optimizing formulations. Secure your supply of high-quality Elacridar from our China-based manufacturing facility.
Neuroscience and CNS Studies
Investigate the blood-brain barrier and develop novel CNS-targeting drugs by utilizing Elacridar's capacity to modulate drug transport. Get a quote for Elacridar to support your research.
Pharmacokinetic (PK) Studies
Elacridar serves as a vital research tool for assessing drug absorption, distribution, metabolism, and excretion (ADME) profiles, particularly concerning efflux transporter interactions. Find a reliable supplier for your PK study needs.